4.5 Article

Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer

期刊

MOLECULAR IMMUNOLOGY
卷 144, 期 -, 页码 117-126

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2022.02.005

关键词

Id3; CD8 exhaustion; PD-1 blockade; Liver cancer

资金

  1. Young and Middle-aged Academic and Technical Leaders in Yunnan Province/Reserve Talent Training Program [202005AC160017]
  2. National Natural Science Foundation of China [81960514]
  3. Project of Kunming Medical [2019FE001-010]
  4. Yunnan Health Training Project of High Level Talents [L-2019016]
  5. Yunnan High-level Talent Cultivation Support Plan-Famous Doctor Special [KH-SWR-MY-2020-001]
  6. Open Project of Gastroenterology Clinical Medicine Center [2021LCZXXF-XH02]
  7. Yunnan Fundamental Research Projects [2022YunJin]

向作者/读者索取更多资源

Id3 plays a protective role in CD8 T cells in liver cancer.
Id3, an inhibitor of DNA binding protein, plays important roles in the function and homeostasis of effector and memory T cells. Recent evidence has shown that Id3 is also implicated in CD8 T cell exhaustion. However, whether and how Id3 might regulate effector function or exhaustion of CD8 T cells, especially in the tumor setting, is still unknown. Here, we first showed that Id3 expression was impaired in tumor-infiltrating CD8 T cells as liver cancer progressed, especially in PD-1+Tim-3 + exhausted CD8 T cells. Enforced expression of Id3 in CD8 T cells resulted in repressed development of anti-tumor CTLs exhaustion, which offered better tumor control. And partially depletion of Id3 in CD8 T cells promoted the development of exhausted CD8 T cells. Furthermore, Id3hi CD8 T cells could respond to PD-1 blockade. Collectively, Id3 exerts protective functions in CD8 T cells for liver cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据